Deidre Jansson, MSc, PhD leads the 2020-2021 UW ADRC Development Project, Defining the cellular and transcriptomics architecture of the CP in Alzheimer's disease: a pilot study.
Dr. Jansson completed her MSc at the University of Ottawa where she studied molecular mechanisms of insulin and calcium signalling in pancreatic beta cells. She completed her PhD in Molecular Neuropharmacology at the University of Auckland, New Zealand where she investigated the role of inflammation and signalling pathway important in human brain pericyte biology. Ongoing projects have branched out to include the use of novel MRI techniques for blood-brain barrier imaging in humans, inflammatory biomarker analysis, as well as ongoing molecular work in human primary cells to identify drug targets for neurodegenerative diseases. New projects in the Iliff lab will surround the role of the choroid plexus in glymphatic clearance, and how this may impact/or be impacted by age-related neurodegeneration.
